Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

67,132 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic impact of MYH9 expression on patients with acute myeloid leukemia.
Yu M, Wang J, Zhu Z, Hu C, Ma Q, Li X, Yin X, Huang J, Zhang T, Ma Z, Zhou Y, Li C, Chen F, Chen J, Wang Y, Pan H, Wang D, Jin J. Yu M, et al. Among authors: zhou y. Oncotarget. 2017 Jan 3;8(1):156-163. doi: 10.18632/oncotarget.10613. Oncotarget. 2017. PMID: 27437869 Free PMC article.
Promising efficacy of novel BTK inhibitor AC0010 in mantle cell lymphoma.
Yan X, Zhou Y, Huang S, Li X, Yu M, Huang J, Wang J, Ma Z, Jin J, Pan J, Li C, Li F, Jin J. Yan X, et al. Among authors: zhou y. J Cancer Res Clin Oncol. 2018 Apr;144(4):697-706. doi: 10.1007/s00432-017-2570-8. Epub 2018 Feb 1. J Cancer Res Clin Oncol. 2018. PMID: 29392403
The high NRF2 expression confers chemotherapy resistance partly through up-regulated DUSP1 in myelodysplastic syndromes.
Lin P, Ren Y, Yan X, Luo Y, Zhang H, Kesarwani M, Bu J, Zhan D, Zhou Y, Tang Y, Zhu S, Xu W, Zhou X, Mei C, Ma L, Ye L, Hu C, Azam M, Ding W, Jin J, Huang G, Tong H. Lin P, et al. Among authors: zhou x, zhou y. Haematologica. 2019 Mar;104(3):485-496. doi: 10.3324/haematol.2018.197749. Epub 2018 Sep 27. Haematologica. 2019. PMID: 30262569 Free PMC article.
High PARP-1 expression predicts poor survival in acute myeloid leukemia and PARP-1 inhibitor and SAHA-bendamustine hybrid inhibitor combination treatment synergistically enhances anti-tumor effects.
Li X, Li C, Jin J, Wang J, Huang J, Ma Z, Huang X, He X, Zhou Y, Xu Y, Yu M, Huang S, Yan X, Li F, Pan J, Wang Y, Yu Y, Jin J. Li X, et al. Among authors: zhou y. EBioMedicine. 2018 Dec;38:47-56. doi: 10.1016/j.ebiom.2018.11.025. Epub 2018 Nov 22. EBioMedicine. 2018. PMID: 30472087 Free PMC article.
67,132 results
You have reached the last available page of results. Please see the User Guide for more information.